Status: Not yet recruiting
Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions
To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.
Participants needed: 36
Trial details
Phase: Phase 1Age: 19-54Biological sex: MaleType: InterventionalSponsor: AJU Pharm Co., Ltd.Updated: Jun 11, 2026Locations: 1
Eligibility criteria
Healthy male adults aged ≥19 years and <55 years at screening. [+4]
Use of medications known to induce or inhibit drug-metabolizing enzymes within 3... [+5]